Peptide-based Anxiolytics: Molecular Aspects of Heptapeptide Selank Biological Activity
Lab research · 2018
- What was studied
- Radioligand binding and isolated brain-cell membrane assays
- Main finding
- The authors examine GABA-binding modulation as a possible mechanistic explanation.
Study data at a glance
- Participants or experimental model
- Radioligand binding and isolated brain-cell membrane assays
- Reported results
- The authors examine GABA-binding modulation as a possible mechanistic explanation.
Study limitations and source details
Study limitations
- Receptor-binding results are laboratory evidence, not proof of clinical efficacy.
- Interactions in an assay do not establish safe combinations with other drugs.
Source details
Journal publication
Indexed citation and English abstract checked; full methods and risk of bias not appraised.
Sources checked
Citation
Tatiana V Vyunova, Lioudmila Andreeva, Konstantin Shevchenko, Nikolay Myasoedov. Peptide-based Anxiolytics: Molecular Aspects of Heptapeptide Selank Biological Activity Curr Mol Pharmacol. PMID 30255741